Citeline Pharma R&D Annual Review 2015 |Pharma Intelligence|

Welcome to Citeline’s 2015 review of trends in pharmaceutical R&D. For around a quarter of a century now, I’ve been taking an annual look at the state of the pharma R&D universe, and comparing it to similar data gathered over the many years during which Pharma projects has led the way in gathering global pharma R&D intelligence.

Citeline Pharma RD Annual Review 2015

Highlights in this paper include:

Total pipeline size
The 2015 Pipeline by phase
Top companies – steady state at the industry’s centre
Top therapy areas and diseases – cancer’s constellation of drugs brightens further
Types of pipeline drugs – the biological frontier edges forward
An ever expanding universe